Abstract

The effect of human papillomavirus (HPV) cotesting in conjunction with cytological cervical screening remains unclear. Investigators in New Mexico (where all Pap results are linked to pathology reports) examined the outcomes of women whose initial cervical screening showed atypical squamous cells of undetermined significance (ASC-US) cytology with or without HPV testing. About 4.5% of the 457,000 women screened between 2008 and 2012 had ASC-US cytology. Of these, 80% underwent HPV testing …

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call